NCT04532307

Brief Summary

Despite advances in efficacious, efficient and safe biomedical tools to reduce HIV transmission and acquisition the HIV epidemic in South Africa(SA) remains an intractable problem, with the lifetime risk of infection approaching 70% for a 15-year-old girl currently living in northern KwaZulu-Natal, the Africa Health Research Institute(AHRI) research setting. This is in part due to the difficulty in engaging adolescents and youth in HIV interventions. We build on formative work to develop and tailor the interventions to young people's needs. Our findings suggested that young people want to focus on sexual and reproductive health(SRH) and value health-promotion from people of their own age and background (peer-support). In a 2016 population-based study of 15-24-year-olds in the study area we found that one in five had a curable Sexually Transmitted Infection(STI) of which three quarters of did not report any symptoms and would not have been cured with current syndromic management. We also found that home-based self-sampling and treatment for STIs was acceptable and desirable to young people. Based on this we developed and conducted a 6-month pilot of the Isisekelo Sempilo adolescent and youth friendly clinics. These are mobile and fixed clinics that are linked to existing primary care services. The clinics deliver nurse-led HIV-testing, prevention and care integrated with SRH. To date n=337 of those referred from the community(\~10%) have attended the clinic. In our setting \>85% of school-leavers are unemployed; there are high levels of common mental disorders which increase with age (rising to 32% of those aged 20-22). Systematic reviews have found that community-based delivery of HIV care and peers are effective in supporting HIV care, adherence and virologic suppression. However, none of these interventions have been tested for HIV-prevention and in youth. Based on this we developed and piloted Thetha Nami, an area-based peer-navigator intervention promoting psychosocial well-being in addition to HIV-prevention to young people aged 15-29. Over a four-month period 24-pairs of peer navigators approached 5872, 15-29-year-old men and women, of which 5272 (90%) accepted the needs assessment. We aim to use advances in intervention design and evaluation to answer the question, "will these tailored HIV-prevention interventions developed in partnership with young people arrest the HIV epidemic and improve well-being?"

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,743

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 12, 2020

Completed
Same day until next milestone

Study Start

First participant enrolled

March 12, 2020

Completed
6 months until next milestone

First Posted

Study publicly available on registry

August 31, 2020

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2022

Completed
Last Updated

January 3, 2024

Status Verified

December 1, 2023

Enrollment Period

2.3 years

First QC Date

March 12, 2020

Last Update Submit

December 29, 2023

Conditions

Keywords

HIV preventionInterventionsPeer supportsexual reproductive health

Outcome Measures

Primary Outcomes (4)

  • Proportion of adolescent and youth who have transmissible HIV

    Measured as the proportion of participants who consent to participate with a detectable HIV viral load (\>400 copies per ml) 12 months after enrolment per arm

    12 months from date of recruitment

  • Proportion of adolescents and youth who uptake HIV prevention and treatment services

    Measured as the proportion of participants who consent who link to clinical services for HIV testing and PrEP/ART counselling within 60 days per arm

    60 days

  • Proportion of adolescents and youth who agree to participate in the trial

    Measured as proportion of those who are eligible consenting to offer of interventions who accept interventions and 12 month follow-up

    12 months

  • Proportion of adolescents and youth from whom the outcome measure of HIV viral load can be ascertained at 12 months follow-up.

    Measured as the proportion of all those enrolled that provide dry blood spots for the measurement of HIV (i.e. proportion with an HIV viral load \>400 copies per ml) in \>75% of those who enrolled at baseline irrespective of engagement in any intervention

    12 months after enrollment

Secondary Outcomes (6)

  • Proportion of adolescent and youth who are HIV positive that start antiretroviral treatment

    12 months

  • Proportion of adolescent and youth who are HIV negative who start PrEP and remain negative

    12 months

  • Proportion of adolescent and youth that have poor sexual health outcome

    12 months

  • Proportion of adolescents and youth that have a poor mental health outcome

    12 months from enrolment

  • Proportion of adolescents and youth that are retained in HIV prevention or care

    12 months from enrolment

  • +1 more secondary outcomes

Other Outcomes (2)

  • Process evaluation

    18 months

  • Costings

    18 months

Study Arms (4)

Standard of Care SOC

EXPERIMENTAL

Youth friendly services at Isisekelo Sempilo clinics

Behavioral: Standard of Care SOC

SRH enhanced Isisekelo Sempilo

EXPERIMENTAL

Self-collected vaginal and urine samples for gonorrhea, chlamydia and trichomonas

Behavioral: Standard of Care SOCBehavioral: SRH enhanced Isisekelo Sempilo

Peer-support (Thetha-Nami)

EXPERIMENTAL

Peer support and needs assessment from an area-based peer navigator

Behavioral: Standard of Care SOCBehavioral: Peer-support (Thetha-Nami)

SOC + SRH + peer-support

EXPERIMENTAL

Combination of all arms

Behavioral: Standard of Care SOCBehavioral: SRH enhanced Isisekelo SempiloBehavioral: Peer-support (Thetha-Nami)Behavioral: SOC + SRH + peer-support

Interventions

Research assistants refer the consenting participants to Isisekelo Sempilo adolescent and youth friendly services with HIV testing, treatment if positive and PrEP eligibility screening and offer if negative and family planning

Peer-support (Thetha-Nami)SOC + SRH + peer-supportSRH enhanced Isisekelo SempiloStandard of Care SOC

Self-collected vaginal and urine samples are collected at enrolment. Research assistants then provide an Isisekelo Sempilo clinic referral appointment for results, treatment, HIV testing, sexual health, fertility, and family planning counselling, including the personal benefits of ART and Undetectable=Uninfectious among those infected, and PrEP for those eligible and who are negative.

SOC + SRH + peer-supportSRH enhanced Isisekelo Sempilo

The research assistants refer the participant to a Thetha Nami peer-navigator in their community. Peer navigators will assess their health, social and educational needs, provide mentorship, and help them access the services they need. The peer navigator will facilitate attendance, adherence and retention at the Isisekelo Sempilo clinic.

Peer-support (Thetha-Nami)SOC + SRH + peer-support

A combination of interventions 2 and 3, to include both self-collected STI testing, nurse led testing and counseling, and referral to a Thetha Nami peer navigator to encourage clinic attendance and sexual health promotion.

SOC + SRH + peer-support

Eligibility Criteria

Age16 Years - 29 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may not qualify if:

  • Under 16 years and above 30 years of age, unable to consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

AHRI

uMkanyakude, KwaZulu-Natal, South Africa

Location

Related Publications (3)

  • Shahmanesh M, Chimbindi N, Busang J, Chidumwa G, Mthiyani N, Herbst C, Okesola N, Dreyer J, Zuma T, Luthuli M, Gumede D, Hlongwane S, Mdluli S, Msane S, Smit T, Molina JM, Khoza T, Behuhuma NO, McGrath N, Seeley J, Harling G, Sherr L, Copas A, Baisley K. Effectiveness of integrating HIV prevention within sexual reproductive health services with or without peer support among adolescents and young adults in rural KwaZulu-Natal, South Africa (Isisekelo Sempilo): 2 x 2 factorial, open-label, randomised controlled trial. Lancet HIV. 2024 Jul;11(7):e449-e460. doi: 10.1016/S2352-3018(24)00119-X.

  • Chidumwa G, Chimbindi N, Herbst C, Okeselo N, Dreyer J, Zuma T, Smith T, Molina JM, Khoza T, McGrath N, Seeley J, Pillay D, Tanser F, Harling G, Sherr L, Copas A, Baisley K, Shahmanesh M. Isisekelo Sempilo study protocol for the effectiveness of HIV prevention embedded in sexual health with or without peer navigator support (Thetha Nami) to reduce prevalence of transmissible HIV amongst adolescents and young adults in rural KwaZulu-Natal: a 2 x 2 factorial randomised controlled trial. BMC Public Health. 2022 Mar 7;22(1):454. doi: 10.1186/s12889-022-12796-8.

  • Shahmanesh M, Okesola N, Chimbindi N, Zuma T, Mdluli S, Mthiyane N, Adeagbo O, Dreyer J, Herbst C, McGrath N, Harling G, Sherr L, Seeley J. Thetha Nami: participatory development of a peer-navigator intervention to deliver biosocial HIV prevention for adolescents and youth in rural South Africa. BMC Public Health. 2021 Jul 13;21(1):1393. doi: 10.1186/s12889-021-11399-z.

MeSH Terms

Interventions

Standard of Care

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Maryam Shahmanesh, PhD

    University College London (UCL) and Africa Health Research Institute (AHRI)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
single blind
Purpose
PREVENTION
Intervention Model
FACTORIAL
Model Details: 2x2 factorial design
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Clinical Epidemiology

Study Record Dates

First Submitted

March 12, 2020

First Posted

August 31, 2020

Study Start

March 12, 2020

Primary Completion

June 30, 2022

Study Completion

September 30, 2022

Last Updated

January 3, 2024

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will share

After study completion data will be stored in Africa Health Research Institute (AHRI) Secure and Safe Data Storage facilities. Data are stored in a database. The database server is located in a secure computer room at the AHRI to which access is restricted to only a few IT professionals. The database is part of the AHRI's Local Area Network, which is protected from outside by a firewall. On the database, the data are stored in MS-SQL Server databases, and access to these is heavily restricted using the features of MS-SQL Server's security subsystem. The AHRI premises are completely surrounded by an electric fence and guarded by a professional security company, 24 hours per day seven days per week. The PI and AHRI data guardian will be responsible for overseeing requests for data sharing. (see below).

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
Data will be available once the primary outcome has been analysed and accepted for publication. We will deposit anonymised IPD data relevant to the analysis in an open access repository at the time of publication.
Access Criteria
The PI and AHRI data guardian will be responsible for overseeing requests for data sharing and that the researchers granted access to the data comply with the terms of the data sharing agreement, which will include honouring any commitments about the use of the data that have been made to participants at the time they granted consent. Researchers will be required to acknowledge the source of the data. The terms will also prohibit researchers attempting to identify participants of the study.

Locations